Genital Lichen Sclerosus in Boys Under 18 Years — Treatment Approach

Genital lichen sclerosus in male patients under 18 years is a paediatric presentation that warrants a specific management strategy. The younger age and thinner skin of this population directly shape treatment selection and the clinical goals pursued.

Clinical scenario: Male patient, age under 18 years, with genital lichen sclerosus. The anatomical characteristics of paediatric skin are a key consideration when choosing and applying topical therapy in this group.

Treatment Overview

The recommended first-line approach uses topical corticosteroid therapy — ultrapotent or potent agents are the cornerstone — alongside topical emollient co-treatment. The complete protocol specifies agent selection, application guidance, course length, and the rationale for paediatric-appropriate choices; that full detail is available through the structured regimen below.

Primary treatment goal: Improvement of the clinical grade of phimosis.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/jdv.20083

We recommend ultrapotent or potent topical corticosteroids in boys with genital lichen sclerosus.

We suggest co-treatment with topical emollients in boys with genital lichen sclerosus.

A placebo-controlled RCT assessed the efficacy of topical MMF 0.05 ointment in treating penile LS in 40 boys after 5 weeks' application.

MMF was found to improve the clinical grade of phimosis in 7/17 boys (41%) after 5-week treatment; no improvement was seen in late disease (the treatment was not curative, and all were circumcised after topical treatment).

View source ↗